The INFORMATION BELOW IS THE JOKE THAT YAZBECK PULLED ON THE PUBLIC
Recent Deals/Partnerships of Interest:
Humanity Products http://humanitymedicine.com On April 9, 2018, the Company verbally agreed to enter into a License and Services Agreement with Humanity Holdings Inc. and Humanity Products, Inc. (collectively “Humanity Holdings”). Humanity Holdings currently operates a manufacturing and distribution facility, licensed by the state of California, through which it engages in the sale and distribution of various cannabis related products. The Company granted Humanity Holdings a non-exclusive license to manufacture, sell, and distribute products within California using proprietary product formulations owned or licensed by the Company. The Company agreed to issue Humanity Holdings shares of Common Stock worth $25,000 on the 45th day following the effective date of the agreement. This is in exchange for Humanity Holdings not contracting with a competitor of the Company who provides formulation services, smart vape device hardware and related software applications to its network, product branding or access to reporting from its data set that ties a user’s experience to a chemical profile of the product they are consuming. Humanity Holdings will pay 20% of net sales to the Company as a support services fee and 30% of net sales to the Company as a royalty. Source: https://www.last10k.com/sec-filings/mydx (see April 2018 10k) Ganja Gold www.ganjagold.org On January 26, 2018 the company entered into a joint venture with Ganja Gold to form “NewCo”. With the formation of NewCo, the intent is for the Parties to manufacture and distribute a new premium line of physiological based Vape formulations under Ganja Gold Vape Brand (“GGV”). The GGV Brand will be powered by MYDX data and formulations utilizing the Eco Smart Pen Device under an exclusive license of MYDX Power Formulations. MyDx will have the option to acquire 50% of NewCo. Source: https://www.last10k.com/sec-filings/mydx (see April 2018 10k) Black Swan Source: https://www.prnewswire.com/news-releases/mydx-enters-into-an-80000-mydx360-saas-licensing-and-services-agreement-with-retailer-blackswan-300475524.html Phylos Biosciences phylosbioscience.com On November 3, 2017 the Company and Phylos Bioscience, Inc. (“Phylos”) entered into a License, Co-Marketing, and Data Sharing Agreement (the “Phylos Agreement”). Pursuant to the Phylos Agreement, the Company and Phylos each granted a non-exclusive license to the other party to access their data and use their trademarks and logo on marketing materials. Neither party paid cash or issued shares in connection with the Phylos Agreement. The license was the consideration given by each party. The term of the agreement is five (5) years. Source: https://seekingalpha.com/filing/3766219 Highsmen https://www.highsmen.com/ Source: https://www.prnewswire.com/news-releases/mydx-forms-exclusive-partnership-with-highsmen-genetics-to-offer-custom-cannabis-strains-tailored-for-desired-physiological-effects-300577228.html Slimpen (aka Q'NCH LLC) slimpen.com & HotNife hotnife.com
In April 2018 the Company verbally agreed to enter into a separate MYDX360 SAAS Ecosystem License and Services Agreements with Q’NCH, LLC, a Delaware limited liability company and HotNife, LLC, a California limited liability company. (the “SAAS Agreements”). Under the terms of the SAAS Agreements, the Company granted the counterparties a non-exclusive limited license to: (i) access the Company’s Database (as defined in the SAAS Agreements) (the “Access License”), and (ii) use the Company’s “Powered by MyDx” trademark and the MyDx logo on the counterparties’ products (the “Brand License”, and together with the Access License, the “MyDx License”). Additionally, the SAAS Agreement provides the counterparties with (i) market research regarding the packaging of the counterparties’ products in coordination with the counterparties’ objectives (the “Brand Services”) and (ii) delivery of certain quantities of the Company’s smart devices, cartridges, batteries, and other hardware to the counterparties (the “Product Services” and, together with the Brand Services, the “MyDx Services”). The total consideration to the Company from each of the counterparties in exchange for the grant of the MyDx License and the MyDx Services will be $15,000 per year and the costs of the Eco Smart Pens’ hardware. The payments will not begin until the Company releases the Eco Smart Pen. The Company expects to release the Eco Smart Pen in the third quarter of 2018.
Source: https://seekingalpha.com/filing/3979293 Unknown National Distributor: (Possibly MedMen, or National CBD Brand) Recent filings and shareholder update show a new contract with a national brand (likely CBD) will be launching soon. Little is known about who it is or when they will launch.
Press: Company Investor Relations Link CannaInsider Interview (2015 & 2018) MYDX reveals the biggest lie in cannabis BNN Interview HBO Vice featuring MYDX How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of 'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants! This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress. SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV. “With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.” We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study. This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine. Marijuana and Potential Long-term Effects Study Goals The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation. The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years. During a visit, participants will be asked to: Give a small blood sample Give a small urine sample Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects). The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders. The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit. MYDX RECRUITS MR. CANNABIS GROUP TO OPERATE COMPANY, https://www.globenewswire.com/news-release/2018/11/13/1650316/0/en/MYDX-RECRUITS-MR-CANNABIS-GROUP-TO-OPERATE-COMPANY.html MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO. https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG MYDX at MEDMEN Headquarters. Quote 'MYDX it’s gonna be a great year' https://www.instagram.com/p/BtMvBI8AbuB/ MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas. CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA
CLAIM against MYDX for NON-DELIVERY of BACK-ORDERED PRODUCT... SEVERAL OTHER LAWSUITS have been filed by Vendors for NON-PAYMENT.. JUDGEMENTS AWARDED! MAY 2019 - MORE TOXIC DEBT! 2 Recent 8K filings. AUGUST 2019 - ECO-SMARTPEN STILL NOT RELEASED!
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 262 views so far. https://www.youtube.com/watch?v=K1gxI0AhR0k&feature=youtu.be&t=50s Powered by MYDX, Ganga Gold video now 502 views, from 3 views, 2 weeks ago. Someones watching. https://youtu.be/5UwxD_5R83w At minute 7:31 you see the GanjaGold labeled box for the EcoSmart Pen on the left next to the PEN!! At minute 7:50 you see the GanjaGold labeled box as well! That’s a labeled GanjaGold box! No prototype!! On January 26, 2018 the Company entered into a joint venture with Ganja Gold to form “NewCo”. With the formation of NewCo, the intent is for the Parties to manufacture and distribute a new premium line of physiological based Vape formulations under Ganja Gold Vape Brand (“GGV Brand”). The GGV Brand will be powered by MYDX data and formulations utilizing the Eco Smart Pen Device under an exclusive license of MYDX Power Formulations. MyDx will have the option to acquire 50% of NewCo. There was no activity in this joint venture during the year ended December 31, 2018.
The MYDX OS:
Number of shares of common stock outstanding as of April 18, 2016 was 22,081,928.
Number of shares of common stock outstanding as of March 23, 2017 was 1,450,204,599. Number of shares of common stock outstanding as of April 16, 2018 was 1,894,397,541.
Number of shares of common stock outstanding as of April 23, 2019 was 3,905,200,946. Number of shares of common stock outstanding as of October 31, 2019 was 5,235,755,336. Number of shares of common stock outstanding as of August 31, 2020 is 6,021,830,220. Number of shares of common stock outstanding as of January 30, 2021 is 7,154,505,824. Number of shares of common stock outstanding as of May 28, 2021 is 8,325,393,103. Number of shares of common stock outstanding as of October 1, 2021 is 8,718,427,339. As of April 7, 2020, OTCMarkets.com has issued a STOP SIGN to MYDX and says the
company is delinquent in its reporting. MYDX has failed to produce its 10-K for 2019 or 2020. In fact, the company did not produce a single
quarterly report in 2020.
The company has also failed to file the required director's report for the State of
Nevada, due 12/31/19. CAVEAT EMPTOR -- MYDX has been issued a skull and crossbones by OTC Markets on
September 17, 2021 for failing to report to the SEC. Addtitionally, MYDX was issued a 12(k) on September 16, 2021 by the SEC -- meaning
suspension of trading through Septemeber 30, 2021.
These are the SEC documents regarding the MYDX suspension:
- Adminstrative Proceeding
-----maintained by 2hk
----above maintained by 2hk